Supplementary Table S2 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Abstract
Mutect2 called and validated variants for each subject and each tumor region from whole exome sequencing data
Fields of Study & Subjects
Glioma Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
vaccines and immunoinformatics approaches
Publication details
- Publication date
- 19 January 2026